Full-Time

Real Estate Portfolio Manager

Posted on 5/9/2026

Option Care Health

Option Care Health

1,001-5,000 employees

Largest independent home infusion therapy provider

Compensation Overview

$100k - $166.6k/yr

Highland Park, IL, USA

Remote

Remote from home; up to 25% travel to US sites.

Category
Real Estate (2)
,
Required Skills
Forecasting
Data Analysis
Excel/Numbers/Sheets
Requirements
  • Bachelor’s degree in Real Estate, Business, Finance, or related field preferred.
  • Minimum of five (5) years of experience in corporate real estate, lease administration, or portfolio management.
  • Strong understanding of commercial lease terms and landlord obligations.
  • Experience managing landlord‑responsible repairs and maintenance activities.
  • Working knowledge of Computerized Maintenance Management System platforms and Facilities coordination workflows.
  • Strong financial acumen, including cost tracking and reimbursement recovery.
  • Advanced Excel and reporting skills.
  • Ability to work independently and manage multiple priorities across location.
  • Travel up to 25% of the time, as required for meetings, site visits, Mergers & Acquisitions due diligence.
Responsibilities
  • Manage the full lifecycle of commercial leases, including renewals, amendments, terminations, and critical date tracking.
  • Maintain accurate lease abstracts, documentation, notices, rent schedules, and option deadlines.
  • Coordinate with Legal and Finance to support lease execution, compliance, and audit readiness.
  • Own portfolio data accuracy across all locations including lease terms, occupancy costs, expiration schedules, and site status.
  • Develop and maintain dashboards and reporting tools for renewals, relocations, closures, and forward-looking decision points.
  • Identify lease execution runway risks and mitigate impacts to construction, relocations, and operational timelines.
  • Support growth and optimization initiatives through market analysis, territory reviews, site strategy development, and site selection support.
  • Research demographics, competitive landscape, access, visibility, labor conditions, and market trends to inform decision-making.
  • Prepare comparative analyses and recommendations for renewals, relocations, expansions, consolidations, and exits.
  • Prepare detailed financial analyses and pro formas evaluating rent, CAM, concessions, tenant improvement allowances, and long-term occupancy cost impacts.
  • Partner with Finance to align real estate assumptions with budgeting, forecasting, and capital planning.
  • Ensure landlord obligations defined in lease agreements are executed, tracked, and financially reconciled.
  • Route, track, and document landlord-responsible work orders through the CMMS with appropriate Facilities visibility and support.
  • Track landlord R&M costs, credits, and reimbursements ensuring financial accountability, recovery, and audit readiness
  • Maintain reporting and audit trails for landlord R&M activity including response times, resolution status, and financial outcomes.
  • Identify recurring landlord issues, non-compliance, or performance concerns and escalate as necessary.
  • Serve as a primary point of contact for landlords, brokers, and property managers related to lease obligations and property matters.
  • Support lease negotiations and enforcement activities through data analysis, documentation, and coordination.
Desired Qualifications
  • Experience supporting healthcare or regulated environments.
  • Familiarity with Facilities Management operations and CMMS-driven workflows.
  • Strong cross-functional communication and stakeholder management skills.

Option Care Health delivers infusion therapies at home and other alternate-site locations across the United States, supported by over 7,000 teammates including about 4,500 clinicians. Clinicians visit patients at home or approved sites to administer therapies, manage care, and coordinate with care teams under strong clinical leadership and national scale. It stands out as the largest independent infusion provider with nationwide reach and a robust clinical workforce, enabling scalable home and alternate-site infusion rather than hospital-only care. The goal is to elevate standards of care and reimagine the infusion care experience by expanding access, improving outcomes, and delivering compassionate, clinically driven service.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Norfolk, Virginia

Founded

1979

Simplify Jobs

Simplify's Take

What believers are saying

  • Expanded revolving credit facility to $850 million enables M&A flexibility.
  • Increased share repurchase authorization to $1 billion signals management confidence.
  • Operating cash flow exceeds $340 million in 2026, growing over 30%.

What critics are saying

  • Chronic Inflammatory Disease portfolio reset causes $55 million revenue headwind through 2026.
  • Stelara biosimilars and Inflation Reduction Act cut gross profit by $25-35 million.
  • EEOC pregnancy discrimination lawsuit triggers fines and talent exodus by 2027.

What makes Option Care Health unique

  • Largest national independent provider of home and alternate site infusion services.
  • Serves over 315,000 unique patients with high-quality infusion therapy options.
  • Selected by Quince Therapeutics for specialty infusion of lead asset eDSP.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Option Care Health who can refer or advise you

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Time Off

Bonding Time Off

401(k) Retirement Plan

401(k) Company Match

Health Savings Account/Flexible Spending Account

Flexible Spending Accounts

Tuition Reimbursement

Family Support

Mental Health Support

Company Paid Life Insurance

Award/Recognition Programs

Company News

Simply Wall St
Apr 4th, 2026
Option Care Health expands credit facility to $850M, boosts buyback to $1B

Option Care Health has expanded its revolving credit facility by $450 million to $850 million and increased its share repurchase authorisation to $1 billion, whilst reaffirming its 2026 guidance. The moves strengthen liquidity and signal management confidence in cash generation. The expanded buyback and credit facility provide greater flexibility for growth investments and capital returns, though near-term focus remains on executing guidance and managing reimbursement pressures. The company's narrative projects $7 billion revenue and $302.2 million earnings by 2029, implying 7.5% annual revenue growth. Analyst fair value estimates range widely from $3.66 to $40.09 per share, with the upper estimate suggesting 46% upside from current prices.

MicroCare
Mar 9th, 2026
MicroCare Medical welcomes Matt Lingenfelter as national sales manager, healthcare.

MicroCare Medical welcomes Matt Lingenfelter as national sales manager, healthcare. March 09, 2026 MicroCare Medical is pleased to welcome Matt Lingenfelter as national sales manager, healthcare. With more than 20 years of experience in healthcare sales and leadership, Matt will help drive national growth and strengthen partnerships for the MicroCare Medical instrument care and infection prevention solutions. In this role, Matt will guide healthcare sales strategy across the U.S., focusing on expanding key accounts, building strong distributor relationships, and supporting the sales team. He will also work closely with marketing, operations, and product development to ensure MicroCare continues delivering solutions that meet the evolving needs of healthcare professionals. Before joining MicroCare, Matt held leadership roles with Option Care Health, Belimed, and Aesculap, where he developed deep expertise in surgical instrumentation, endoscopic technologies, and hospital system support. "Matt's experience and understanding of healthcare systems make him a fantastic addition to our team," said Ray Bellavance, vice president of global sales and marketing at MicroCare. "We're excited to have him help grow our healthcare business and strengthen partnerships across the country."

Yahoo Finance
Feb 27th, 2026
Option Care Health posts 13% revenue growth despite $25M–35M Stelara biosimilar headwind

Option Care Health reported a 13% revenue increase in Q4 2025, with acute therapies growing in the mid-teens and chronic therapies in the low double digits. The company served over 315,000 unique patients and improved operational efficiency, with 40% of claims now processed without human intervention. For 2026, the company issued revenue guidance of $5.8 billion to $6 billion, incorporating a 400 basis point headwind from Stelara biosimilar conversions and Inflation Reduction Act impacts. Adjusted EBITDA is projected at $480 million to $505 million, accounting for a $25 million to $35 million gross profit headwind from Stelara transitions. Operating cash flow is expected to exceed $340 million, representing over 30% growth. The company plans to launch at least two new pharmaceutical manufacturer programmes and expand its infusion clinic model to support higher-acuity therapies.

PREEMPT, Inc
Sep 30th, 2025
EEOC Sues Option Care Health, Inc. for Pregnancy Discrimination

EEOC sues Option Care Health, Inc. for pregnancy discrimination.

Option Care Health
Aug 7th, 2025
Quince Therapeutics Selects Option Care Health as Specialty Infusion Therapy Provider for Administration of Lead Asset eDSP

Quince Therapeutics selects Option Care Health as specialty infusion therapy provider for administration of lead asset eDSP.